Cargando…
Discovery of New Uracil and Thiouracil Derivatives as Potential HDAC Inhibitors
Background: Histone deacetylase inhibitors (HDACIs) are a relatively new class of potential drugs for treating cancer. Aim: Discovery of new anticancer agents targeting HDAC. Methods: New uracil and thiouracil derivatives panels were designed and synthesized as HDAC inhibitors. The synthesized compo...
Autores principales: | Elbatrawy, Omnia R., Hagras, Mohamed, El Deeb, Moshira A., Agili, Fatimah, Hegazy, Maghawry, El-Husseiny, Ahmed A., Mokhtar, Mahmoud Mohamed, Elkhawaga, Samy Y., Eissa, Ibrahim H., El-Kalyoubi, Samar |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10384246/ https://www.ncbi.nlm.nih.gov/pubmed/37513878 http://dx.doi.org/10.3390/ph16070966 |
Ejemplares similares
-
A Novel Synthesis of Fused Uracils: Indenopyrimidopyridazines, Pyrimidopyridazines, and Pyrazolopyrimidines for Antimicrobial and Antitumor Evalution
por: El-Kalyoubi, Samar, et al.
Publicado: (2016) -
Synthesis, In Silico Prediction and In Vitro Evaluation of Antimicrobial Activity, DFT Calculation and Theoretical Investigation of Novel Xanthines and Uracil Containing Imidazolone Derivatives
por: El-Kalyoubi, Samar, et al.
Publicado: (2021) -
Synthesis, In Silico Prediction and In Vitro Evaluation of Antitumor Activities of Novel Pyrido[2,3-d]pyrimidine, Xanthine and Lumazine Derivatives
por: El-Kalyoubi, Samar, et al.
Publicado: (2020) -
Discovery of new quinolines as potent colchicine binding site inhibitors: design, synthesis, docking studies, and anti-proliferative evaluation
por: Hagras, Mohamed, et al.
Publicado: (2021) -
Uracil as a Zn-Binding Bioisostere of the Allergic Benzenesulfonamide in the Design of Quinoline–Uracil Hybrids as Anticancer Carbonic Anhydrase Inhibitors
por: El-Kalyoubi, Samar A., et al.
Publicado: (2022)